Statin Market 2023-2027

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global statin market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global statin market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user
6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Hospitals - Market size and forecast 2022-2027
Exhibit 34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
6.4 Clinics - Market size and forecast 2022-2027
Exhibit 38: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Clinics - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
6.5 Others - Market size and forecast 2022-2027
Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by End-user
Exhibit 46: Market opportunity by End-user ($ million)
Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Type
7.1 Market segments
Exhibit 48: Chart on Type - Market share 2022-2027 (%)
Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 50: Chart on Comparison by Type
Exhibit 51: Data Table on Comparison by Type
7.3 Synthetic statin - Market size and forecast 2022-2027
Exhibit 52: Chart on Synthetic statin - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Synthetic statin - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Synthetic statin - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Synthetic statin - Year-over-year growth 2022-2027 (%)
7.4 Natural statin - Market size and forecast 2022-2027
Exhibit 56: Chart on Natural statin - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Natural statin - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Natural statin - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Natural statin - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Type
Exhibit 60: Market opportunity by Type ($ million)
Exhibit 61: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Asia - Market size and forecast 2022-2027
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.5 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Canada - Market size and forecast 2022-2027
Exhibit 87: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 Japan - Market size and forecast 2022-2027
Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.11 Germany - Market size and forecast 2022-2027
Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 111: Abbott Laboratories - Overview
Exhibit 112: Abbott Laboratories - Business segments
Exhibit 113: Abbott Laboratories - Key news
Exhibit 114: Abbott Laboratories - Key offerings
Exhibit 115: Abbott Laboratories - Segment focus
12.4 Amgen Inc.
Exhibit 116: Amgen Inc. - Overview
Exhibit 117: Amgen Inc. - Product/Service
Exhibit 118: Amgen Inc. - Key offerings
12.5 AstraZeneca Plc
Exhibit 119: AstraZeneca Plc - Overview
Exhibit 120: AstraZeneca Plc - Product/Service
Exhibit 121: AstraZeneca Plc - Key news
Exhibit 122: AstraZeneca Plc - Key offerings
12.6 Aurobindo Pharma Ltd.
Exhibit 123: Aurobindo Pharma Ltd. - Overview
Exhibit 124: Aurobindo Pharma Ltd. - Product/Service
Exhibit 125: Aurobindo Pharma Ltd. - Key offerings
12.7 Biocon Ltd.
Exhibit 126: Biocon Ltd. - Overview
Exhibit 127: Biocon Ltd. - Business segments
Exhibit 128: Biocon Ltd. - Key offerings
Exhibit 129: Biocon Ltd. - Segment focus
12.8 Concord Biotech Ltd.
Exhibit 130: Concord Biotech Ltd. - Overview
Exhibit 131: Concord Biotech Ltd. - Product/Service
Exhibit 132: Concord Biotech Ltd. - Key offerings
12.9 Merck and Co. Inc.
Exhibit 133: Merck and Co. Inc. - Overview
Exhibit 134: Merck and Co. Inc. - Business segments
Exhibit 135: Merck and Co. Inc. - Key news
Exhibit 136: Merck and Co. Inc. - Key offerings
Exhibit 137: Merck and Co. Inc. - Segment focus
12.10 Novartis AG
Exhibit 138: Novartis AG - Overview
Exhibit 139: Novartis AG - Business segments
Exhibit 140: Novartis AG - Key offerings
Exhibit 141: Novartis AG - Segment focus
12.11 Pfizer Inc.
Exhibit 142: Pfizer Inc. - Overview
Exhibit 143: Pfizer Inc. - Product/Service
Exhibit 144: Pfizer Inc. - Key news
Exhibit 145: Pfizer Inc. - Key offerings
12.12 Thermo Fisher Scientific Inc.
Exhibit 146: Thermo Fisher Scientific Inc. - Overview
Exhibit 147: Thermo Fisher Scientific Inc. - Business segments
Exhibit 148: Thermo Fisher Scientific Inc. - Key news
Exhibit 149: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 150: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 151: Inclusions checklist
Exhibit 152: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 153: Currency conversion rates for US$
13.4 Research methodology
Exhibit 154: Research methodology
Exhibit 155: Validation techniques employed for market sizing
Exhibit 156: Information sources
13.5 List of abbreviations
Exhibit 157: List of abbreviations

List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global statin market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on End-user - Market share 2022-2027 (%)
Exhibits 31: Data Table on End-user - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by End-user
Exhibits 33: Data Table on Comparison by End-user
Exhibits 34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Clinics - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 46: Market opportunity by End-user ($ million)
Exhibits 47: Data Table on Market opportunity by End-user ($ million)
Exhibits 48: Chart on Type - Market share 2022-2027 (%)
Exhibits 49: Data Table on Type - Market share 2022-2027 (%)
Exhibits 50: Chart on Comparison by Type
Exhibits 51: Data Table on Comparison by Type
Exhibits 52: Chart on Synthetic statin - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Data Table on Synthetic statin - Market size and forecast 2022-2027 ($ million)
Exhibits 54: Chart on Synthetic statin - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Synthetic statin - Year-over-year growth 2022-2027 (%)
Exhibits 56: Chart on Natural statin - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Data Table on Natural statin - Market size and forecast 2022-2027 ($ million)
Exhibits 58: Chart on Natural statin - Year-over-year growth 2022-2027 (%)
Exhibits 59: Data Table on Natural statin - Year-over-year growth 2022-2027 (%)
Exhibits 60: Market opportunity by Type ($ million)
Exhibits 61: Data Table on Market opportunity by Type ($ million)
Exhibits 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 65: Chart on Geographic comparison
Exhibits 66: Data Table on Geographic comparison
Exhibits 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 103: Market opportunity By Geographical Landscape ($ million)
Exhibits 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 105: Impact of drivers and challenges in 2022 and 2027
Exhibits 106: Overview on Criticality of inputs and Factors of differentiation
Exhibits 107: Overview on factors of disruption
Exhibits 108: Impact of key risks on business
Exhibits 109: Vendors covered
Exhibits 110: Matrix on vendor position and classification
Exhibits 111: Abbott Laboratories - Overview
Exhibits 112: Abbott Laboratories - Business segments
Exhibits 113: Abbott Laboratories - Key news
Exhibits 114: Abbott Laboratories - Key offerings
Exhibits 115: Abbott Laboratories - Segment focus
Exhibits 116: Amgen Inc. - Overview
Exhibits 117: Amgen Inc. - Product/Service
Exhibits 118: Amgen Inc. - Key offerings
Exhibits 119: AstraZeneca Plc - Overview
Exhibits 120: AstraZeneca Plc - Product/Service
Exhibits 121: AstraZeneca Plc - Key news
Exhibits 122: AstraZeneca Plc - Key offerings
Exhibits 123: Aurobindo Pharma Ltd. - Overview
Exhibits 124: Aurobindo Pharma Ltd. - Product/Service
Exhibits 125: Aurobindo Pharma Ltd. - Key offerings
Exhibits 126: Biocon Ltd. - Overview
Exhibits 127: Biocon Ltd. - Business segments
Exhibits 128: Biocon Ltd. - Key offerings
Exhibits 129: Biocon Ltd. - Segment focus
Exhibits 130: Concord Biotech Ltd. - Overview
Exhibits 131: Concord Biotech Ltd. - Product/Service
Exhibits 132: Concord Biotech Ltd. - Key offerings
Exhibits 133: Merck and Co. Inc. - Overview
Exhibits 134: Merck and Co. Inc. - Business segments
Exhibits 135: Merck and Co. Inc. - Key news
Exhibits 136: Merck and Co. Inc. - Key offerings
Exhibits 137: Merck and Co. Inc. - Segment focus
Exhibits 138: Novartis AG - Overview
Exhibits 139: Novartis AG - Business segments
Exhibits 140: Novartis AG - Key offerings
Exhibits 141: Novartis AG - Segment focus
Exhibits 142: Pfizer Inc. - Overview
Exhibits 143: Pfizer Inc. - Product/Service
Exhibits 144: Pfizer Inc. - Key news
Exhibits 145: Pfizer Inc. - Key offerings
Exhibits 146: Thermo Fisher Scientific Inc. - Overview
Exhibits 147: Thermo Fisher Scientific Inc. - Business segments
Exhibits 148: Thermo Fisher Scientific Inc. - Key news
Exhibits 149: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 150: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 151: Inclusions checklist
Exhibits 152: Exclusions checklist
Exhibits 153: Currency conversion rates for US$
Exhibits 154: Research methodology
Exhibits 155: Validation techniques employed for market sizing
Exhibits 156: Information sources
Exhibits 157: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global statin market: Abbott Laboratories, Amgen Inc., AstraZeneca Plc, Aurobindo Pharma Ltd., Biocon Ltd., Concord Biotech Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is strong incidence of CHD.'

According to the report, one of the major drivers for this market is the rising prevalence of hypercholesterolemia.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

• Abbott Laboratories
• Amgen Inc.
• AstraZeneca Plc
• Aurobindo Pharma Ltd.
• Biocon Ltd.
• Concord Biotech Ltd.
• Merck and Co. Inc.
• Novartis AG
• Pfizer Inc.
• Thermo Fisher Scientific Inc.